Abstract
We explored methodological issues related to antiretroviral adherence assessment, using 6 months of data collected in a completed intervention trial involving 136 low-income HIV-positive outpatients in the Bronx, NY. Findings suggest that operationalizing adherence as a continuous (versus dichotomous) variable and averaging adherence estimates over multiple assessment points (versus using only one) explains greater variance in HIV-1 RNA viral load (VL). Self-reported estimates provided during a phone interview accounted for similar variance in VL as EDM estimates (R 2 = .17 phone versus .18 EDM). Self-reported adherence was not associated with a standard social desirability measure, and no difference in the accuracy of self-report adherence was observed for assessment periods of 1–3 days. Self-reported poor adherence was more closely associated with EDM adherence estimates than self-reported moderate and high adherence. On average across assessment points, fewer than 4% of participants who reported taking a dose of an incorrect amount of medication.
Similar content being viewed by others
References
Ammassari, A., Trotta, M., Murri, R., Castelli, F., Narciso, P., Noto, P. et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S123–S127.
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R.W., Gourevitch, M. N., Chang, C. J. et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(8), 1417–1423.
Bangsberg, D. R. (2004). U.S. researcher starts treatment fund in Uganda: Interview with David Bangsberg, M.D., M.P.H. AIDS Treatment News (402), 3–5.
Bangsberg, D. R., Bronstone, A., Chesney, M. A., & Hecht, F. M. (2002). Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. Journal of Acquired Immune Deficiency Syndromes, 31(3), S107–S111.
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Chesney, M. A., & Moss, A. (2001). Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior, 5, 272–281.
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L. et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.
Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M. et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 26(5), 435–442.
Bova, C. A., Fennie, K. P., Knafl, G. J., Dieckhaus, K. D., Watrous, E., & Williams, A. B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS and Behavior, 9(1), 103–110.
Chesney, M. (1999). The challenge of adherence. Bulletin of Experimental Treatments for AIDS, 12(1), 10–13.
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B. et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255–266.
Crowne, D., & Marlow, D. (1964). Social desirability scale. In the approval motive. John Wiley and Sons Inc.: New York.
Deschamps, A. E., Graeve, V. D., van Wijngaerden, E., De Saar, V., Vandamme, A. M., van Vaerenbergh, K. et al. (2004). Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care and STDS, 18(11), 644–657.
Di Matteo, M. R., Hays, R. D., & Gritz, E. R. (1993). Patient adherence to cancer control regimens: Scale development and initial validation. Psychological Assessment, 5, 101–112.
Dunbar-Jacob, J., & Schlenk, E. (2001). Patient adherence to treatment regimen. In A. Baum, T. A. Revenson, & J. E. Singer (Eds.), Handbook of health psychology (pp. 571–580). Mahwah: NJ.
Duong, M., Piroth, L., Peytavin, G., Forte, F., Kohli, E., Grappin, M. et al. (2001). Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. Clinical Infectious Diseases, 33(3), 386–392 Epub 2001 Jun 2021.
Gao, X., & Nau, D. P. (2000). Congruence of three self-report measures of medication adherence among HIV patients. Annals of Pharmacotherapy, 34(10), 1117–1122.
Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J. et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17(10), 756–765.
Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E. et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16(16), 2175–2182.
Hugen, P.W., Burger, D. M., Aarnoutse, R. E., Baede, P. A., Nieuwkerk, P. T., Koopmans, P. P., & Hekster, Y. A. (2002). Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance. Theraputic Drug Monitoring, 24(5), 579–587.
Hugen, P. W., Langebeek, N., Burger, D. M., Zomer, B., van Leusen, R., Schuurman, R. et al. (2002). Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. Journal of Acquired Immune Deficiency Syndrome, 30(3), 324–334.
Johnson, R. L., Botwinick, G., Sell, R. L., Martinez, J., Siciliano, C., Friedman, L. B. et al. (2003). The utilization of treatment and case management services by HIV-infected youth. Journal of Adolescent Health, 33(2 Suppl), 31–38.
Kalichman, S. C., Cain, D., Fuhrel, A., Eaton, L., Di Fonzo, K., & Ertl, T. (2005). Assessing medication adherence self-efficacy among low-literacy patients: development of a pictographic visual analogue scale. Health Education Research, 20(1), 24–35.
Kimmerling, M., Wagner, G., & Ghosh-Dastidar, B. (2003). Factors associated with accurate self-reported adherence to HIV antiretrovirals. International Journal of STD and AIDS, 14(4), 281–284.
Knobel, H., Guelar, A., Carmona, A., Espona, M., Gonzalez, A., Lopez-Colomes, J. L. et al. (2001). Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care and STDs, 15, 193–199.
Lievens, F. (2002). Trying to understand the different pieces of the construct validity puzzle of assessment centers: An examination of assessor and assessee effects. Journal of Applied Psychology, 87(4), 675–686.
Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S. et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968–977.
Llabre, M. M., Weaver, K. E., Durán, R. E., Antoni, M. H., McPherson-Baker, S., Klimas, N. et al. (2006). A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV+ Adults. AIDS Care and STD.
Melbourne, K. M., Geletko, S. M., Brown, S. L., Willey-Lessne, C., Chase, S., & Fisher, A. (1999). Medication adherence in patients with HIV infection: A comparison of two measurement methods. AIDS Read, 9(5), 329–338.
Miller, L. G., & Hays, R. D. (2000a). Adherence to combination antiretroviral therapy: Synthesis of the literature and clinical implications. The AIDS Reader, 10(3), 177–185.
Miller, L. G., & Hays, R. D. (2000b). Measuring adherence to antiretroviral medications in clinical trials. HIV Clinical Trials, 1(1), 36–46.
Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 76–74.
Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D. et al. (2000). Patient-reported nonadherence to HAART is related to protease inhibitor levels. Journal of Acquired Immunodeficiency Syndromes, 24(2), 123–128.
Nieuwkerk, P. T. (2003). Electronic monitoring of adherence to highly active antiretroviral therapy changes medication-taking behaviour? AIDS, 17(9), 1417–1418.
Nieuwkerk, P. T., & Oort, F. J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 38(4), 445–448.
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487–497.
Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P. et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes, 36(5), 1100–1102.
Parienti, J. J., Verdon, R., Bazin, C., Bouvet, E., Massari, V., & Larouze, B. (2001). The pills identification test: A tool to assess adherence to antiretroviral therapy. JAMA, 285(4), 412.
Paterson, D., Potoski, B., & Capitano, B. (2002). Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndromes, 31, S103–S106.
Paterson, D., Swindells, S., Mohr, J., Brester, M., Vergis, E., Squier, C. et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30.
Reynolds, N. R. (2004). Adherence to antiretroviral therapies: State of the science. Current HIV Research, 2(3), 207–214.
Rogers, S. M., Willis, G., Al-Tayyib, A., Villarroel, M. A., Turner, C. F., Ganapathi, L. et al. (2005). Audio computer assisted interviewing to measure HIV risk behaviours in a clinic population. Sexually Transmitted Infections, 81(6), 501–507.
Rudd, P., Byyny, R. L., Zachary, V., LoVerde, M. E., Mitchell, W. D., Titus, C. et al. (1988). Pill count measures of compliance in a drug trial: Variability and suitability. American Journal of Hypertension, 1(3 Pt 1), 309–312.
Samet, J. H., Sullivan, L. M., Traphagen, E. T., & Ickovics, J. R. (2002). Measuring adherence among HIV-infected persons: Is MEMS consummate technology? AIDS and Behavior, 5(1), 21–30.
Sankar, A., Neufeld, S., Nevedal, D., & Luborsky, M. (2006). What is a missed dose? Implications or construct validity and patient adherence. AIDS Care.
Simoni, J. M., Frick, P.A., & Huang, B. (2006). A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology, 25, 74–81.
Simoni, J. M., Frick, P. A., Pantalone, D. W., & Turner, B. J. (2003). Antiretroviral adherence interventions: A review of current literature and ongoing studies. Topics in HIV Medicine, 11(6), 185–198.
Simoni J. M., Kurth A., Pearson C. R., Pantalone D. W., Merrill J., & Frick P. A. (2006). A review of self-report measures of HIV antiretroviral adherence. AIDS and Behavior.
Simoni, J. M., Pantalone, D. W., Plummer, M. D., & Huang, B. (in press). A randomized controlled trial of a peer support intervention to improve antiretroviral adherence and decrease depressive symptomatology among HIV-positive individuals. Health Psychology.
Streiner, D. L. (2002). Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Canadian Journal of Psychiatry, 47(3), 262–266.
Turner, B. (2002). Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. The Journal of Infectious Diseases, 185 (Suppl 2), S143–151.
Turner, B. J., & Hecht, F. M. (2001). Improving on a coin toss to predict patient adherence to medications. Annals of Internal Medicine, 134(10), 1004–1006.
Wagner, G., & Miller, L. G. (2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndromes, 35(2), 203–204.
Wagner, G. J. (2003). Does discontinuing the use of pill boxes to facilitate electronic monitoring impede adherence? International Journal of STD and AIDS, 14(1), 64–65.
Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2003). Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS, 17(4), 179–186.
Wagner, G. J., & Rabkin, J. G. (2000). Measuring medication adherence: Are missed doses reported more accurately then perfect adherence? AIDS Care, 12(4), 405–408.
Walsh, J. C., Horne, R., Dalton, M., Burgess, A. P., & Gazzard, B. G. (2001). Reasons for non-adherence to antiretroviral therapy: patients’ perspectives provide evidence of multiple causes. AIDS Care, 13(6), 709–720.
Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16(2), 269–277.
Wendel, C. S., Mohler, M. J., Kroesen, K., Ampel, N. M., Gifford, A. L., & Coons, S. J. (2001). Barriers to use of electronic adherence monitoring in an HIV clinic. Annals of Pharmacotherapy, 35(9), 1010–1015.
Wewers, M. E., & Lowe, N. K. (1990). A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health, 13(4), 227–236.
Wutoh, A., Elekwachi, O., Clarke-Tasker, V., Daftary, M., Powell, N., & Campusano, G. (2003). Assessment and predictors of antiretroviral adherence in older HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 33(2), S106–S114.
Acknowledgments
This work was supported by Stroum Endowed Minority Dissertation Fellowship funding to Dr. Cynthia Pearson, University of Washington Center for AIDS Research Sociobehavioral and Prevention Research Core (P30 AI 27757) funding to Dr. Kurth, and 2 R01 MH58986 to Dr. Simoni.
Author information
Authors and Affiliations
Corresponding author
Additional information
Despite hundreds of empirical studies and thousands of papers written about patient adherence and compliance, the question of how best to measure it is still an open one. (Di Matteo, Hays, & Gritz, 1993).
Rights and permissions
About this article
Cite this article
Pearson, C.R., Simoni, J.M., Hoff, P. et al. Assessing Antiretroviral Adherence via Electronic Drug Monitoring and Self-Report: An Examination of Key Methodological Issues. AIDS Behav 11, 161–173 (2007). https://doi.org/10.1007/s10461-006-9133-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-006-9133-3